Martin Gottwik

发表

Primary angioplasty in acute myocardial infarction: differences between referred patients and those treated in hospitals with on-site facilities?

R. Schiele, M. Gottwik, T. Voigtländer, 1999, The Journal of invasive cardiology.

Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction Registry and the Myocardial Infarction Regis

R. Schiele, S. Schneider, A. Gitt, 2001, Journal of the American College of Cardiology.

Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS).

M. Gottwik, U. Tebbe, M. Weber, 1988, Journal of the American College of Cardiology.

Visualization of coronary artery anomalies and their anatomic course by contrast-enhanced electron beam tomography and three-dimensional reconstruction.

S. Achenbach, D. Ropers, W. Daniel, 2001, The American journal of cardiology.

In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer Kra

A. Gitt, U. Zeymer, K. Seidl, 2005, Heart.

Daytime and nighttime differences in patterns of performance of primary angioplasty in the treatment of patients with acute myocardial infarction. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group.

R. Schiele, M. Gottwik, T. Voigtländer, 1999, American heart journal.

Spectrum of reperfusion strategies and factors influencing the use of primary angioplasty in patients with acute myocardial infarction admitted to hospitals with the facilities to perform primary angioplasty

R. Schiele, M. Gottwik, T. Voigtländer, 1999, Heart.

Volume–outcome relation for contemporary percutaneous coronary interventions (PCI) in daily clinical practice: is it limited to high-risk patients? Results from the Registry of Percutaneous Coronary Interventions of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)

R. Dietz, T. Meinertz, M. Hochadel, 2007, Heart.

Effect of preinfarction angina pectoris on outcome in patients with acute myocardial infarction treated with primary angioplasty (results from the Myocardial Infarction Registry.

G. Schuler, R. Schiele, S. Schneider, 2001, The American journal of cardiology.

Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis.

R. Schiele, S. Schneider, A. Gitt, 2001, American heart journal.

The 60 minutes myocardial infarction project. Treatment and clinical outcome of patients with acute myocardial infarction in Germany.

R. Schiele, M. Gottwik, J. Senges, 1997, European heart journal.

Beneficial effects of abciximab in patients with primary percutaneous intervention for acute ST segment elevation myocardial infarction in clinical practice

T. Heer, A. Gitt, H. Wienbergen, 2006, Heart.

[Balloon dilatation in acute myocardial infarct in routine clinical practice: results of the register of the Working Society of Leading Cardiologic Hospital Physicians in 4,625 patients].

M. Gottwik, K. Seidl, K. Neuhaus, 1997, Zeitschrift fur Kardiologie.

The 60 Minutes Myocardial Infarction Project. Characteristics on admission and clinical outcome in patients with reinfarction compared to patients with a first infarction.

R. Schiele, M. Gottwik, S. Wagner, 1998, European heart journal.